Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Sokolowska, Milena (24081481900)"

Filter results by typing the first few letters
Now showing 1 - 6 of 6
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
    (2024)
    Redel, Anne-Lotte (58947794300)
    ;
    Feleszko, Wojciech (6603916811)
    ;
    Arcolaci, Alessandra (57200242157)
    ;
    Cefaloni, Francesca (58639370400)
    ;
    Atanaskovic-Markovic, Marina (6506020842)
    ;
    Braunstahl, Gert-Jan (6603192008)
    ;
    Boccabella, Cristina (57196050691)
    ;
    Bonini, Matteo (55751094200)
    ;
    Karavelia, Aspasia (57218201130)
    ;
    Louwers, Eefje (58947794400)
    ;
    Mülleneisen, Norbert (6602223170)
    ;
    O'Mahony, Liam (6701714264)
    ;
    Pini, Laura (7006303227)
    ;
    Rapiejko, Anna (57219904010)
    ;
    Shehu, Esmeralda (58947629600)
    ;
    Sokolowska, Milena (24081481900)
    ;
    Untersmayr, Eva (6505909709)
    ;
    Tramper-Stranders, Gerdien (13405694700)
    Introduction: Guidelines recommend treating asthma exacerbations (AAEs) with bronchodilators combined with inhaled and/or systemic corticosteroids. Indications for antibiotic prescriptions for AAEs are usually not incorporated although the literature shows antibiotics are frequently prescribed. Aim: To investigate the antibiotic prescription rates in AAEs and explore the possible determining factors of those practices. Methods: A digital survey was created to determine the antibiotic prescription rates in AAEs and the influencing factors for the prescription practices. The survey was distributed among European academy of allergy and clinical immunology (EAACI) members by mass emailing and through regional/national societies in the Netherlands, Italy, Greece, and Poland. Furthermore, we retrieved local antibiotic prescription rates. Results: In total, 252 participants completed the survey. Respondents stated that there is a lack of guidelines to prescribe antibiotics in AAEs. The median antibiotic prescription rate in this study was 19% [IQR: 0%–40%] and was significantly different between 4 professions: paediatrics 0% [IQR: 0%–37%], pulmonologists 25% [IQR: 10%–50%], general practitioners 25% [IQR: 0%–50%], and allergologists 17% [IQR: 0%–33%]) (p = 0.046). Additional diagnostic tests were performed in 71.4% of patients before prescription and the most common antibiotic classes prescribed were macrolides (46.0%) and penicillin (42.9%). Important clinical factors for health care providers to prescribe antibiotics were colorised/purulent sputum, abnormal lung sounds during auscultation, fever, and presence of comorbidities. Conclusion: In 19% of patients with AAEs, antibiotics were prescribed in various classes with a broad range among different subspecialities. This study stresses the urgency to compose evidence-based guidelines to aim for more rational antibiotic prescriptions for AAE. © 2024 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
    (2024)
    Redel, Anne-Lotte (58947794300)
    ;
    Feleszko, Wojciech (6603916811)
    ;
    Arcolaci, Alessandra (57200242157)
    ;
    Cefaloni, Francesca (58639370400)
    ;
    Atanaskovic-Markovic, Marina (6506020842)
    ;
    Braunstahl, Gert-Jan (6603192008)
    ;
    Boccabella, Cristina (57196050691)
    ;
    Bonini, Matteo (55751094200)
    ;
    Karavelia, Aspasia (57218201130)
    ;
    Louwers, Eefje (58947794400)
    ;
    Mülleneisen, Norbert (6602223170)
    ;
    O'Mahony, Liam (6701714264)
    ;
    Pini, Laura (7006303227)
    ;
    Rapiejko, Anna (57219904010)
    ;
    Shehu, Esmeralda (58947629600)
    ;
    Sokolowska, Milena (24081481900)
    ;
    Untersmayr, Eva (6505909709)
    ;
    Tramper-Stranders, Gerdien (13405694700)
    Introduction: Guidelines recommend treating asthma exacerbations (AAEs) with bronchodilators combined with inhaled and/or systemic corticosteroids. Indications for antibiotic prescriptions for AAEs are usually not incorporated although the literature shows antibiotics are frequently prescribed. Aim: To investigate the antibiotic prescription rates in AAEs and explore the possible determining factors of those practices. Methods: A digital survey was created to determine the antibiotic prescription rates in AAEs and the influencing factors for the prescription practices. The survey was distributed among European academy of allergy and clinical immunology (EAACI) members by mass emailing and through regional/national societies in the Netherlands, Italy, Greece, and Poland. Furthermore, we retrieved local antibiotic prescription rates. Results: In total, 252 participants completed the survey. Respondents stated that there is a lack of guidelines to prescribe antibiotics in AAEs. The median antibiotic prescription rate in this study was 19% [IQR: 0%–40%] and was significantly different between 4 professions: paediatrics 0% [IQR: 0%–37%], pulmonologists 25% [IQR: 10%–50%], general practitioners 25% [IQR: 0%–50%], and allergologists 17% [IQR: 0%–33%]) (p = 0.046). Additional diagnostic tests were performed in 71.4% of patients before prescription and the most common antibiotic classes prescribed were macrolides (46.0%) and penicillin (42.9%). Important clinical factors for health care providers to prescribe antibiotics were colorised/purulent sputum, abnormal lung sounds during auscultation, fever, and presence of comorbidities. Conclusion: In 19% of patients with AAEs, antibiotics were prescribed in various classes with a broad range among different subspecialities. This study stresses the urgency to compose evidence-based guidelines to aim for more rational antibiotic prescriptions for AAE. © 2024 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Dangerous liaisons: Bacteria, antimicrobial therapies, and allergic diseases
    (2021)
    Tramper-Stranders, Gerdien (13405694700)
    ;
    Ambrożej, Dominika (57211938585)
    ;
    Arcolaci, Alessandra (57200242157)
    ;
    Atanaskovic-Markovic, Marina (6506020842)
    ;
    Boccabella, Cristina (57196050691)
    ;
    Bonini, Matteo (55751094200)
    ;
    Karavelia, Aspasia (57218201130)
    ;
    Mingomataj, Ervin (6505892725)
    ;
    O' Mahony, Liam (57219617067)
    ;
    Sokolowska, Milena (24081481900)
    ;
    Untersmayr, Eva (6505909709)
    ;
    Feleszko, Wojciech (6603916811)
    Microbiota composition and associated metabolic activities are essential for the education and development of a healthy immune system. Microbial dysbiosis, caused by risk factors such as diet, birth mode, or early infant antimicrobial therapy, is associated with the inception of allergic diseases. In turn, allergic diseases increase the risk for irrational use of antimicrobial therapy. Microbial therapies, such as probiotics, have been studied in the prevention and treatment of allergic diseases, but evidence remains limited due to studies with high heterogeneity, strain-dependent effectiveness, and variable outcome measures. In this review, we sketch the relation of microbiota with allergic diseases, the overuse and rationale for the use of antimicrobial agents in allergic diseases, and current knowledge concerning the use of bacterial products in allergic diseases. We urgently recommend 1) limiting antibiotic therapy in pregnancy and early childhood as a method contributing to the reduction of the allergy epidemic in children and 2) restricting antibiotic therapy in exacerbations and chronic treatment of allergic diseases, mainly concerning asthma and atopic dermatitis. Future research should be aimed at antibiotic stewardship implementation strategies and biomarker-guided therapy, discerning those patients that might benefit from antibiotic therapy. © 2021 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Dangerous liaisons: Bacteria, antimicrobial therapies, and allergic diseases
    (2021)
    Tramper-Stranders, Gerdien (13405694700)
    ;
    Ambrożej, Dominika (57211938585)
    ;
    Arcolaci, Alessandra (57200242157)
    ;
    Atanaskovic-Markovic, Marina (6506020842)
    ;
    Boccabella, Cristina (57196050691)
    ;
    Bonini, Matteo (55751094200)
    ;
    Karavelia, Aspasia (57218201130)
    ;
    Mingomataj, Ervin (6505892725)
    ;
    O' Mahony, Liam (57219617067)
    ;
    Sokolowska, Milena (24081481900)
    ;
    Untersmayr, Eva (6505909709)
    ;
    Feleszko, Wojciech (6603916811)
    Microbiota composition and associated metabolic activities are essential for the education and development of a healthy immune system. Microbial dysbiosis, caused by risk factors such as diet, birth mode, or early infant antimicrobial therapy, is associated with the inception of allergic diseases. In turn, allergic diseases increase the risk for irrational use of antimicrobial therapy. Microbial therapies, such as probiotics, have been studied in the prevention and treatment of allergic diseases, but evidence remains limited due to studies with high heterogeneity, strain-dependent effectiveness, and variable outcome measures. In this review, we sketch the relation of microbiota with allergic diseases, the overuse and rationale for the use of antimicrobial agents in allergic diseases, and current knowledge concerning the use of bacterial products in allergic diseases. We urgently recommend 1) limiting antibiotic therapy in pregnancy and early childhood as a method contributing to the reduction of the allergy epidemic in children and 2) restricting antibiotic therapy in exacerbations and chronic treatment of allergic diseases, mainly concerning asthma and atopic dermatitis. Future research should be aimed at antibiotic stewardship implementation strategies and biomarker-guided therapy, discerning those patients that might benefit from antibiotic therapy. © 2021 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Management of anaphylaxis due to COVID-19 vaccines in the elderly
    (2021)
    Bousquet, Jean (55156315400)
    ;
    Agache, Ioana (57201020933)
    ;
    Blain, Hubert (16687865700)
    ;
    Jutel, Marek (7004260631)
    ;
    Ventura, Maria Teresa (7201760331)
    ;
    Worm, Margitta (34573859300)
    ;
    Del Giacco, Stefano (55828150411)
    ;
    Benetos, Athanasios (56844949800)
    ;
    Bilo, Beatrice Maria (6701329982)
    ;
    Czarlewski, Wienczyslawa (57203909023)
    ;
    Abdul Latiff, Amir Hamzah (55608026700)
    ;
    Al-Ahmad, Mona (8927100400)
    ;
    Angier, Elizabeth (35557982000)
    ;
    Annesi-Maesano, Isabella (56229296400)
    ;
    Atanaskovic-Markovic, Marina (6506020842)
    ;
    Bachert, Claus (7102663930)
    ;
    Barbaud, Annick (7102785517)
    ;
    Bedbrook, Anna (55253648100)
    ;
    Bennoor, Kazi S. (6507273839)
    ;
    Berghea, Elena Camelia (9232969200)
    ;
    Bindslev-Jensen, Carsten (7004294156)
    ;
    Bonini, Sergio (8739114400)
    ;
    Bosnic-Anticevich, Sinthia (7801624496)
    ;
    Brockow, Knut (7003392139)
    ;
    Brussino, Luisa (6701711701)
    ;
    Camargos, Paulo (7004508954)
    ;
    Canonica, G. Walter (55412658800)
    ;
    Cardona, Victoria (18133374200)
    ;
    Carreiro-Martins, Pedro (36114454200)
    ;
    Carriazo, Ana (56562887300)
    ;
    Casale, Thomas (7005524902)
    ;
    Caubet, Jean-Christoph (36460677400)
    ;
    Cecchi, Lorenzo (57193526705)
    ;
    Cherubini, Antonio (7005767834)
    ;
    Christoff, George (55941056200)
    ;
    Chu, Derek K. (24491429400)
    ;
    Cruz, Alvaro A. (55512188000)
    ;
    Dokic, Dejan (6603576505)
    ;
    El-Gamal, Yehia (6602867770)
    ;
    Ebisawa, Motohiro (7004186010)
    ;
    Eberlein, Bernadette (57204958526)
    ;
    Farrell, John (56562483700)
    ;
    Fernandez-Rivas, Montserrat (56684808700)
    ;
    Fokkens, Wytske J. (35355799700)
    ;
    Fonseca, Joao A. (45661083200)
    ;
    Gao, Yadong (35798243100)
    ;
    Gavazzi, Gaëtan (15820719800)
    ;
    Gawlik, Radoslaw (55973853500)
    ;
    Gelincik, Asli (55913588100)
    ;
    Gemicioğlu, Bilun (6505921956)
    ;
    Gotua, Maia (22634363800)
    ;
    Guérin, Olivier (6603632918)
    ;
    Haahtela, Tari (7004531314)
    ;
    Hoffmann-Sommergruber, Karin (56231539900)
    ;
    Hoffmann, Hans Jürgen (55966113000)
    ;
    Hofmann, Maja (8632864700)
    ;
    Hrubisko, Martin (56235598300)
    ;
    Illario, Maddalena (6507765583)
    ;
    Irani, Carla (6701412303)
    ;
    Ispayeva, Zhanat (57194692514)
    ;
    Ivancevich, Juan Carlos (23091137000)
    ;
    Julge, Kaja (55147363200)
    ;
    Kaidashev, Igor (6603855774)
    ;
    Khaitov, Musa (7801543864)
    ;
    Knol, Edward (7007059464)
    ;
    Kraxner, Helga (6507277473)
    ;
    Kuna, Piotr (7006421186)
    ;
    Kvedariene, Violeta (14056134900)
    ;
    Lauerma, Antti (7004140830)
    ;
    Le, Lan T. T. (55570089700)
    ;
    Le Moing, Vincent (7004193887)
    ;
    Levin, Michael (35233829300)
    ;
    Louis, Renaud (55556102200)
    ;
    Lourenco, Olga (57208574707)
    ;
    Mahler, Vera (7003943682)
    ;
    Martin, Finbarr C. (7403519729)
    ;
    Matucci, Andrea (6701469558)
    ;
    Milenkovic, Branislava (23005307400)
    ;
    Miot, Stéphanie (23103921400)
    ;
    Montella, Emma (55621391200)
    ;
    Morais-Almeida, Mario (6602654955)
    ;
    Mortz, Charlotte G. (6602289977)
    ;
    Mullol, Joaquim (55972415400)
    ;
    Namazova-Baranova, Leyla (48761908100)
    ;
    Neffen, Hugo (57743157900)
    ;
    Nekam, Kristof (7003852891)
    ;
    Niedoszytko, Marek (6603308598)
    ;
    Odemyr, Mikaëla (57205576034)
    ;
    O’Hehir, Robyn E. (57205068606)
    ;
    Okamoto, Yoshitaka (57211783510)
    ;
    Ollert, Markus (7004161698)
    ;
    Palomares, Oscar (6505979777)
    ;
    Papadopoulos, Nikolaos G. (35354006800)
    ;
    Panzner, Petr (6602408250)
    ;
    Passalacqua, Giovanni (7007067199)
    ;
    Patella, Vincenzo (7004792918)
    ;
    Petrovic, Mirko (15837843200)
    ;
    Pfaar, Oliver (9744229500)
    ;
    Pham-Thi, Nhân (57193002159)
    ;
    Plavec, Davor (6603896808)
    ;
    Popov, Todor A. (7006088089)
    ;
    Recto, Marysia T. (57193521921)
    ;
    Regateiro, Frederico S. (8859661600)
    ;
    Reynes, Jacques (57220428984)
    ;
    Roller-Winsberger, Regina E. (59158492500)
    ;
    Rolland, Yves (7007024863)
    ;
    Romano, Antonino (7201571602)
    ;
    Rondon, Carmen (16182305300)
    ;
    Rottem, Menachem (7003875042)
    ;
    Rouadi, Philip W. (6507628553)
    ;
    Salles, Nathalie (15756205800)
    ;
    Samolinski, Boleslaw (57194529979)
    ;
    Santos, Alexandra F. (57173488700)
    ;
    S Sarquis, Faradiba (57280716900)
    ;
    Sastre, Joaquin (14326067900)
    ;
    M. G. A. Schols, Jos (57280840700)
    ;
    Scichilone, Nicola (6602470530)
    ;
    Sediva, Anna (7003573645)
    ;
    Shamji, Mohamed H. (57210446924)
    ;
    Sheikh, Aziz (7202522962)
    ;
    Skypala, Isabel (6506185305)
    ;
    Smolinska, Sylwia (55445173700)
    ;
    Sokolowska, Milena (24081481900)
    ;
    Sousa-Pinto, Bernardo (55982726300)
    ;
    Sova, Milan (36549506300)
    ;
    Stelmach, Rafael (6602983023)
    ;
    Sturm, Gunter (7006421822)
    ;
    Suppli Ulrik, Charlotte (7004960246)
    ;
    Todo-Bom, Ana Maria (15847298500)
    ;
    Toppila-Salmi, Sanna (14631330000)
    ;
    Tsiligianni, Ioanna (8315152700)
    ;
    Torres, Maria (58280986000)
    ;
    Untersmayr, Eva (6505909709)
    ;
    Urrutia Pereira, Marilyn (56574378400)
    ;
    Valiulis, Arunas (57204694158)
    ;
    Vitte, Joana (6507197544)
    ;
    Vultaggio, Alessandra (6507889718)
    ;
    Wallace, Dana (24475867900)
    ;
    Walusiak-Skorupa, Jolanta (54895954800)
    ;
    Wang, De-Yun (57222705920)
    ;
    Waserman, Susan (6602359228)
    ;
    Yorgancioglu, Arzu (57210951407)
    ;
    Yusuf, Osman M. (23973974800)
    ;
    Zernotti, Mario (8401439400)
    ;
    Zidarn, Mihaela (57205729265)
    ;
    Chivato, Tomas (6701522636)
    ;
    Akdis, Cezmi A. (7007154667)
    ;
    Zuberbier, Torsten (7004554588)
    ;
    Klimek, Ludger (7005088080)
    Older adults, especially men and/or those with diabetes, hypertension, and/or obesity, are prone to severe COVID-19. In some countries, older adults, particularly those residing in nursing homes, have been prioritized to receive COVID-19 vaccines due to high risk of death. In very rare instances, the COVID-19 vaccines can induce anaphylaxis, and the management of anaphylaxis in older people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis and its Impact on Asthma, European Academy of Allergy and Clinical Immunology, and European Geriatric Medicine Society) Working Group has proposed some recommendations for older adults receiving the COVID-19 vaccines. Anaphylaxis to COVID-19 vaccines is extremely rare (from 1 per 100,000 to 5 per million injections). Symptoms are similar in younger and older adults but they tend to be more severe in the older patients. Adrenaline is the mainstay treatment and should be readily available. A flowchart is proposed to manage anaphylaxis in the older patients. © 2021 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Management of anaphylaxis due to COVID-19 vaccines in the elderly
    (2021)
    Bousquet, Jean (55156315400)
    ;
    Agache, Ioana (57201020933)
    ;
    Blain, Hubert (16687865700)
    ;
    Jutel, Marek (7004260631)
    ;
    Ventura, Maria Teresa (7201760331)
    ;
    Worm, Margitta (34573859300)
    ;
    Del Giacco, Stefano (55828150411)
    ;
    Benetos, Athanasios (56844949800)
    ;
    Bilo, Beatrice Maria (6701329982)
    ;
    Czarlewski, Wienczyslawa (57203909023)
    ;
    Abdul Latiff, Amir Hamzah (55608026700)
    ;
    Al-Ahmad, Mona (8927100400)
    ;
    Angier, Elizabeth (35557982000)
    ;
    Annesi-Maesano, Isabella (56229296400)
    ;
    Atanaskovic-Markovic, Marina (6506020842)
    ;
    Bachert, Claus (7102663930)
    ;
    Barbaud, Annick (7102785517)
    ;
    Bedbrook, Anna (55253648100)
    ;
    Bennoor, Kazi S. (6507273839)
    ;
    Berghea, Elena Camelia (9232969200)
    ;
    Bindslev-Jensen, Carsten (7004294156)
    ;
    Bonini, Sergio (8739114400)
    ;
    Bosnic-Anticevich, Sinthia (7801624496)
    ;
    Brockow, Knut (7003392139)
    ;
    Brussino, Luisa (6701711701)
    ;
    Camargos, Paulo (7004508954)
    ;
    Canonica, G. Walter (55412658800)
    ;
    Cardona, Victoria (18133374200)
    ;
    Carreiro-Martins, Pedro (36114454200)
    ;
    Carriazo, Ana (56562887300)
    ;
    Casale, Thomas (7005524902)
    ;
    Caubet, Jean-Christoph (36460677400)
    ;
    Cecchi, Lorenzo (57193526705)
    ;
    Cherubini, Antonio (7005767834)
    ;
    Christoff, George (55941056200)
    ;
    Chu, Derek K. (24491429400)
    ;
    Cruz, Alvaro A. (55512188000)
    ;
    Dokic, Dejan (6603576505)
    ;
    El-Gamal, Yehia (6602867770)
    ;
    Ebisawa, Motohiro (7004186010)
    ;
    Eberlein, Bernadette (57204958526)
    ;
    Farrell, John (56562483700)
    ;
    Fernandez-Rivas, Montserrat (56684808700)
    ;
    Fokkens, Wytske J. (35355799700)
    ;
    Fonseca, Joao A. (45661083200)
    ;
    Gao, Yadong (35798243100)
    ;
    Gavazzi, Gaëtan (15820719800)
    ;
    Gawlik, Radoslaw (55973853500)
    ;
    Gelincik, Asli (55913588100)
    ;
    Gemicioğlu, Bilun (6505921956)
    ;
    Gotua, Maia (22634363800)
    ;
    Guérin, Olivier (6603632918)
    ;
    Haahtela, Tari (7004531314)
    ;
    Hoffmann-Sommergruber, Karin (56231539900)
    ;
    Hoffmann, Hans Jürgen (55966113000)
    ;
    Hofmann, Maja (8632864700)
    ;
    Hrubisko, Martin (56235598300)
    ;
    Illario, Maddalena (6507765583)
    ;
    Irani, Carla (6701412303)
    ;
    Ispayeva, Zhanat (57194692514)
    ;
    Ivancevich, Juan Carlos (23091137000)
    ;
    Julge, Kaja (55147363200)
    ;
    Kaidashev, Igor (6603855774)
    ;
    Khaitov, Musa (7801543864)
    ;
    Knol, Edward (7007059464)
    ;
    Kraxner, Helga (6507277473)
    ;
    Kuna, Piotr (7006421186)
    ;
    Kvedariene, Violeta (14056134900)
    ;
    Lauerma, Antti (7004140830)
    ;
    Le, Lan T. T. (55570089700)
    ;
    Le Moing, Vincent (7004193887)
    ;
    Levin, Michael (35233829300)
    ;
    Louis, Renaud (55556102200)
    ;
    Lourenco, Olga (57208574707)
    ;
    Mahler, Vera (7003943682)
    ;
    Martin, Finbarr C. (7403519729)
    ;
    Matucci, Andrea (6701469558)
    ;
    Milenkovic, Branislava (23005307400)
    ;
    Miot, Stéphanie (23103921400)
    ;
    Montella, Emma (55621391200)
    ;
    Morais-Almeida, Mario (6602654955)
    ;
    Mortz, Charlotte G. (6602289977)
    ;
    Mullol, Joaquim (55972415400)
    ;
    Namazova-Baranova, Leyla (48761908100)
    ;
    Neffen, Hugo (57743157900)
    ;
    Nekam, Kristof (7003852891)
    ;
    Niedoszytko, Marek (6603308598)
    ;
    Odemyr, Mikaëla (57205576034)
    ;
    O’Hehir, Robyn E. (57205068606)
    ;
    Okamoto, Yoshitaka (57211783510)
    ;
    Ollert, Markus (7004161698)
    ;
    Palomares, Oscar (6505979777)
    ;
    Papadopoulos, Nikolaos G. (35354006800)
    ;
    Panzner, Petr (6602408250)
    ;
    Passalacqua, Giovanni (7007067199)
    ;
    Patella, Vincenzo (7004792918)
    ;
    Petrovic, Mirko (15837843200)
    ;
    Pfaar, Oliver (9744229500)
    ;
    Pham-Thi, Nhân (57193002159)
    ;
    Plavec, Davor (6603896808)
    ;
    Popov, Todor A. (7006088089)
    ;
    Recto, Marysia T. (57193521921)
    ;
    Regateiro, Frederico S. (8859661600)
    ;
    Reynes, Jacques (57220428984)
    ;
    Roller-Winsberger, Regina E. (59158492500)
    ;
    Rolland, Yves (7007024863)
    ;
    Romano, Antonino (7201571602)
    ;
    Rondon, Carmen (16182305300)
    ;
    Rottem, Menachem (7003875042)
    ;
    Rouadi, Philip W. (6507628553)
    ;
    Salles, Nathalie (15756205800)
    ;
    Samolinski, Boleslaw (57194529979)
    ;
    Santos, Alexandra F. (57173488700)
    ;
    S Sarquis, Faradiba (57280716900)
    ;
    Sastre, Joaquin (14326067900)
    ;
    M. G. A. Schols, Jos (57280840700)
    ;
    Scichilone, Nicola (6602470530)
    ;
    Sediva, Anna (7003573645)
    ;
    Shamji, Mohamed H. (57210446924)
    ;
    Sheikh, Aziz (7202522962)
    ;
    Skypala, Isabel (6506185305)
    ;
    Smolinska, Sylwia (55445173700)
    ;
    Sokolowska, Milena (24081481900)
    ;
    Sousa-Pinto, Bernardo (55982726300)
    ;
    Sova, Milan (36549506300)
    ;
    Stelmach, Rafael (6602983023)
    ;
    Sturm, Gunter (7006421822)
    ;
    Suppli Ulrik, Charlotte (7004960246)
    ;
    Todo-Bom, Ana Maria (15847298500)
    ;
    Toppila-Salmi, Sanna (14631330000)
    ;
    Tsiligianni, Ioanna (8315152700)
    ;
    Torres, Maria (58280986000)
    ;
    Untersmayr, Eva (6505909709)
    ;
    Urrutia Pereira, Marilyn (56574378400)
    ;
    Valiulis, Arunas (57204694158)
    ;
    Vitte, Joana (6507197544)
    ;
    Vultaggio, Alessandra (6507889718)
    ;
    Wallace, Dana (24475867900)
    ;
    Walusiak-Skorupa, Jolanta (54895954800)
    ;
    Wang, De-Yun (57222705920)
    ;
    Waserman, Susan (6602359228)
    ;
    Yorgancioglu, Arzu (57210951407)
    ;
    Yusuf, Osman M. (23973974800)
    ;
    Zernotti, Mario (8401439400)
    ;
    Zidarn, Mihaela (57205729265)
    ;
    Chivato, Tomas (6701522636)
    ;
    Akdis, Cezmi A. (7007154667)
    ;
    Zuberbier, Torsten (7004554588)
    ;
    Klimek, Ludger (7005088080)
    Older adults, especially men and/or those with diabetes, hypertension, and/or obesity, are prone to severe COVID-19. In some countries, older adults, particularly those residing in nursing homes, have been prioritized to receive COVID-19 vaccines due to high risk of death. In very rare instances, the COVID-19 vaccines can induce anaphylaxis, and the management of anaphylaxis in older people should be considered carefully. An ARIA-EAACI-EuGMS (Allergic Rhinitis and its Impact on Asthma, European Academy of Allergy and Clinical Immunology, and European Geriatric Medicine Society) Working Group has proposed some recommendations for older adults receiving the COVID-19 vaccines. Anaphylaxis to COVID-19 vaccines is extremely rare (from 1 per 100,000 to 5 per million injections). Symptoms are similar in younger and older adults but they tend to be more severe in the older patients. Adrenaline is the mainstay treatment and should be readily available. A flowchart is proposed to manage anaphylaxis in the older patients. © 2021 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback